In contrast, induction of AP-2β expression has been found to impair tumour cell proliferation and slow tumour progression by enhancing both differentiation of noradrenergic neurons as well as noradrenergic signalling through increased expression of TH and DBH [33]. The gene discussed is TFAP2B; the disease is neoplasm.